CMPS // COMPASS Pathways Plc American Depository Shares
ANR <GO> NASDAQ RQD COCKPIT → CIK 0001816590 ↗ Health Care • Biotechnology: Pharmaceutical Preparations
$12.19 ▼ -0.09
(-0.73%)
MKT CAP: $1.69B • VOL: 1.38M
52W L $5 52W H $16
ROARABLE / RQD
D- • 37/100
PIOTROSKI
1 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$10
MEDIAN
$14
MEAN
$14
HIGH
$17
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE CMPS TAPE
CMPS // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $14.75 | $14.02 | 2025-02-14 | $11.09 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $15.36 | $14.38 | 2025-02-06 | $11.46 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $13.90 | $13.41 | 2025-01-29 | $11.70 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $12.43 | — | 2025-01-17 | $11.95 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $10.73 | $11.58 | 2025-01-09 | $10.85 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $14.51 | $12.68 | 2024-12-18 | $10.61 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $11.82 | $12.31 | 2024-12-04 | $11.34 | -4.3% | 48% | C |